SFTA2 was also identified as prognostic genes with significantly correlation with the pathological stages of pancreatic ductal adenocarcinoma in an integrated transcriptome meta-analysis (Atay, 2020). This evidence concerns the gene SFTA2 and pancreatic ductal adenocarcinoma.